(TheNewswire)
Edmonton, Alberta - TheNewswire - July 17, 2023 - Innovotech (IOT:TSXV) has appointed JulieWright as a director of the Company effective immediately.
Wright is President of (W)right On Communications Inc, anaward-winning integrated strategic communications firm she founded in1998 with a head office in San Diego, Calif. Her industry experiencespans the cleantech, energy, healthcare, high-tech, life sciences,manufacturing, tourism and travel sectors, among others, with clientsranging from startups through Fortune 500 companies.
Wright will be granted 50,000 incentive stock options at $0.10exercisable over five years.
Wright currently serves on the Board of Directors of CanBiocin Inc., aprivately-held Edmonton-based companion animal and livestock probioticinnovator, and as chair of Vancouver-based Lonsdale CapitalCorporation. She is a director and past chair of the San Diego NorthEconomic Development Council and a current director of Cal Travel, theadvocacy organization for California’s travel and tourism industry.
Wright holds a Bachelor of Arts degree from the University of BritishColumbia and a Master of Journalism degree from the Graduate School ofJournalism at the University of Western Ontario. She is a graduateof the Governance Academy of the Corporate Director’s Forum.
About Innovotech
Innovotech is a Canadian biotechnology company owningproprietary intellectual property, conducting contract research, andowning and providing proprietary devices for testing in multipleapplications in microbiology. Innovotech can be found online at www.innovotech.ca .
James G. Timourian
President
Innovotech Inc.
This document may containforward-looking statements that are predictive in nature and subjectto risks and uncertainties that cannot be predicted or quantified;consequently, actual results may differ materially from past resultsand those expressed or implied by any forward-looking statements.Factors that could cause or contribute to such risks or uncertaintiesinclude, but are not limited to: the regulatory environment includingthe difficulty of predicting regulatory outcomes; changes in the valueof the Canadian dollar; the Company’s reliance on a small number ofcustomers including government organizations; fluctuations inoperating results; government policies or actions; progress and costof clinical trials; reliance on key strategic relationships;uncertainty related to intellectual property protection and potentialcosts associated with its defense; the Company’s exposure tolawsuits and other matters beyond the control of management. Shouldknown or unknown risks or uncertainties materialize, or shouldmanagement’s assumptions prove inaccurate, actual results could varymaterially from those anticipated. The Company undertakes noobligation to publicly make or update any forward-looking statements,except as required by applicable law.
Neither TSX Venture Exchange nor its RegulationServices Provider (as that term is defined in the policies of the TSXVenture Exchange) accepts responsibility for the adequacy or accuracyof this release.
Copyright (c) 2023 TheNewswire - All rights reserved.